Frank J. Dellafera, a Director, acquired 1,250,000 Common Shares cat?gorie A on an indirect ownership basis for registered holder Alfera Pharmaceuticals, LLC at a price of $0.400 through a prospectus or prospectus exempt offering on April 23rd, 2024. The insider also acquired 1,250,000 Warrants on an indirect ownership basis for registered holder Alfera Pharmaceuticals, LLC with an exercise price of $0.700 for 36 months. This represents a $500,000 investment into the company's shares and an account share holdings change of greater than 100%.
LSL Pharma Group is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company. The Company is specializing in the development, manufacturing and distribution of natural health products and dietary supplements in solid dosage forms, as well as sterile ophthalmic pharmaceutical products. The Company's subsidiaries include Steri-Med Pharma Inc., LSL Laboratory Inc. and Groupe Immobilier LSL inc.
No Comments